Skip to main content

Novanta Inc. (NOVT) Stock Analysis

Range Bound setup · Catalyst-Driven edge

HoldVALUE-TRAP 1/5Moderate Confidence

Technology · Scientific & Technical Instruments

Hold if already holding. Not a fresh buy at $129.72, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Elevated risk factors.

Novanta supplies core technology components (precision motion, laser subsystems, advanced surgery systems, RFID) to medical, life science, and advanced industrial OEMs. Its solutions target long-lifecycle OEM customer platforms in niche markets. Approximately 47% of fiscal 2025... Read more

$129.72+2.9% A.UpsideScore 5.4/10#6 of 14 Scientific & Technical Instruments
Stop $120.64Target $133.45(analyst − 15%)A.R:R 0.2:1
Analyst target$157.00+21.0%2 analysts
$133.45our TP
$129.72price
$157.00mean
$170

Hold if already holding. Not a fresh buy at $129.72, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Elevated risk factors. Chart setup: RSI 52 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.4/10, moderate confidence.

Passes 5/7 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (4/4)
Earnings estimates trending UP
Strong growth profile
Risks
Analyst target reached - limited upside remaining
Elevated risk factors

Key Metrics

P/E (TTM)88.7
P/E (Fwd)32.0
Mkt Cap$4.6B
EV/EBITDA25.5
Profit Mgn5.5%
ROE5.2%
Rev Growth8.5%
Beta1.65
DividendNone
Rating analysts10

Quality Signals

Piotroski F9/9

Options Flow

P/C0.10bullish
IV77%elevated
Max Pain$55-57.6% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicinternational revenue (outside U.S.)47%
    10-K Item 1A: 'During the year ended December 31, 2025, approximately 47% of our revenues were from customers outside of the U.S.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
1.4
Value Rank
3.2
Growth Rank
5.0
GatesA.R:R 0.2 < 1.5@spotEARNINGS PROXIMITY 10d<=14d (soft)Momentum 6.6>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
52 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $113.15Resistance $137.48

Price Targets

$121
$133
A.Upside+2.9%
A.R:R0.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (2.9% upside)
! NEWS_MOD=+1: SELL_IF_HOLDING → HOLD_IF_HOLDING
! Reward/Risk 0.2:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-11 (10d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NOVT stock a buy right now?

Hold if already holding. Not a fresh buy at $129.72, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Elevated risk factors. Chart setup: RSI 52 mid-range, Bollinger mid-band. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $133.45 (+2.9%), stop $120.64 (−7.5%), A.R:R 0.2:1. Score 5.4/10, moderate confidence.

What is the NOVT stock price target?

Take-profit target: $133.45 (+2.9% upside). Target $133.45 (+2.9%), stop $120.64 (−7.5%), A.R:R 0.2:1. Stop-loss: $120.64.

What are the risks of investing in NOVT?

Analyst target reached - limited upside remaining; Elevated risk factors.

Is NOVT overvalued or undervalued?

Novanta Inc. trades at a P/E of 88.7 (forward 32.0). TrendMatrix value score: 5.1/10. Verdict: Hold.

What do analysts say about NOVT?

10 analysts cover NOVT with a consensus score of 4.2/5. Average price target: $157.

What does Novanta Inc. do?Novanta supplies core technology components (precision motion, laser subsystems, advanced surgery systems, RFID) to...

Novanta supplies core technology components (precision motion, laser subsystems, advanced surgery systems, RFID) to medical, life science, and advanced industrial OEMs. Its solutions target long-lifecycle OEM customer platforms in niche markets. Approximately 47% of fiscal 2025 revenues came from customers outside the U.S.

Related stocks: VNT (Vontier Corporation) · ESE (ESCO Technologies Inc.) · FTV (Fortive Corporation) · TRMB (Trimble Inc.) · TDY (Teledyne Technologies Incorpora)